Record
Loading…
Record
Loading…
organization · fact
As of November 8, 2026, the latest revenue figure on the AsOf record for Gilead Sciences is $8.3 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). Gilead Sciences's latest full-year revenue is $29.44 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared.
| value | valid from | valid to | status | conf | sources | claim |
|---|---|---|---|---|---|---|
| $4.23 billion: revenue 4,230,045,000 United States dollar from 2007-12-31, claim clm_2896D3FD1A51 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_2896D3FD1A51 | ||||
| $5.34 billion: revenue 5,335,750,000 United States dollar from 2008-12-31, claim clm_78AFDF7AC308 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_78AFDF7AC308 | ||||
| $7.01 billion: revenue 7,011,383,000 United States dollar from 2009-12-31, claim clm_23ACEDC261B0 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_23ACEDC261B0 | ||||
| $7.95 billion: revenue 7,949,420,000 United States dollar from 2010-12-31, claim clm_819CF52FBEB1 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_819CF52FBEB1 | ||||
| $8.39 billion: revenue 8,385,385,000 United States dollar from 2011-12-31, claim clm_3C7AA6C6D6B9 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_3C7AA6C6D6B9 | ||||
| $9.7 billion: revenue 9,702,517,000 United States dollar from 2012-12-31, claim clm_6D4418F572A9 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_6D4418F572A9 | ||||
| $11.2 billion: revenue 11,201,688,000 United States dollar from 2013-12-31, claim clm_C43DA4F79044 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_C43DA4F79044 | ||||
| $24.89 billion: revenue 24,890,000,000 United States dollar from 2014-12-31, claim clm_617CC39EB4D4 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_617CC39EB4D4 | ||||
| $32.64 billion: revenue 32,639,000,000 United States dollar from 2015-12-31, claim clm_963EB0743197 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_963EB0743197 | ||||
| $30.39 billion: revenue 30,390,000,000 United States dollar from 2016-12-31, claim clm_FC87519132B6 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_FC87519132B6 | ||||
| $26.11 billion: revenue 26,107,000,000 United States dollar from 2017-12-31, claim clm_27E7D83B62B4 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_27E7D83B62B4 | ||||
| $22.13 billion: revenue 22,127,000,000 United States dollar from 2018-12-31, claim clm_2C70360428CB and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_2C70360428CB | ||||
| $22.45 billion: revenue 22,449,000,000 United States dollar from 2019-12-31, claim clm_43120E77E428 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_43120E77E428 | ||||
| $24.69 billion: revenue 24,689,000,000 United States dollar from 2020-12-31, claim clm_BCA2F683C1DE and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_BCA2F683C1DE | ||||
| $27.31 billion: revenue 27,305,000,000 United States dollar from 2021-12-31, claim clm_D6C1A036D30A and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_D6C1A036D30A | ||||
| $27.28 billion: revenue 27,281,000,000 United States dollar from 2022-12-31, claim clm_63D857B5C382 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_63D857B5C382 | ||||
| $27.12 billion: revenue 27,116,000,000 United States dollar from 2023-12-31, claim clm_ABFE2CB3CF48 and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_ABFE2CB3CF48 | ||||
| $28.75 billion: revenue 28,754,000,000 United States dollar from 2024-12-31, claim clm_766F0DC2656D and its sources | superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted. | clm_766F0DC2656D | ||||
| $29.44 billion: revenue 29,443,000,000 United States dollar from 2025-12-31, claim clm_5E2D1C5DC1DC and its sources | valid: Two independent sources agree, or a primary source states it: the record asserts this claim. | clm_5E2D1C5DC1DC |
AsOf. "Gilead Sciences quarterly revenue: 8,300,000,000 United States dollar", as of 2026-09-30. Claim clm_64E20B8C7E0A, https://asof.is/claim/clm_64E20B8C7E0A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm.
AsOf. (2026). Gilead Sciences quarterly revenue: 8,300,000,000 United States dollar (as of 2026-09-30) [Record clm_64E20B8C7E0A]. Retrieved November 8, 2026, from https://asof.is/claim/clm_64E20B8C7E0A (source: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm)
@misc{asof_clm_64E20B8C7E0A,
author = {AsOf},
title = {Gilead Sciences quarterly revenue: 8,300,000,000 United States dollar},
year = {2026},
howpublished = {\url{https://asof.is/claim/clm_64E20B8C7E0A}},
note = {Claim clm\_64E20B8C7E0A, as of 2026-09-30; source: https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/0000882095-26-000039-index.htm},
urldate = {2026-11-08}
}